Mohammad et al. tested the effect of a PCR2 complex subunit (EZH2) inhibitor on 6 DMG cell lines, as well as a pediatric GBM cell line with a wild-type H3 and a GBM cell line with a G34R mutation in H3.3. The gene discussed is EZH2; the disease is glioblastoma.